Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Further experimentation of inhaled; LANTUS, ACTRAPID and HUMULIN with todays' production systems.

Zarogoulidis P, Petridis D, Ritzoulis C, Li Q, Huang H, Ning Y, Darwiche K, Freitag L, Zarogoulidis K.

Int J Pharm. 2013 Dec 15;458(1):39-47. doi: 10.1016/j.ijpharm.2013.10.019. Epub 2013 Oct 17.

PMID:
24140545
2.

Experimentation with inhaled bronchodilators and corticosteroids.

Zarogoulidis P, Porpodis K, Kioumis I, Petridis D, Lampaki S, Spyratos D, Papaiwannou A, Organtzis J, Kontakiotis T, Manika K, Darwiche K, Freitag L, Tsiouda T, Papakosta D, Zarogoulidis K.

Int J Pharm. 2014 Jan 30;461(1-2):411-8. doi: 10.1016/j.ijpharm.2013.12.010. Epub 2013 Dec 17.

PMID:
24361267
3.

Internal mouthpiece designs as a future perspective for enhanced aerosol deposition. Comparative results for aerosol chemotherapy and aerosol antibiotics.

Zarogoulidis P, Petridis D, Ritzoulis C, Darwiche K, Kioumis I, Porpodis K, Spyratos D, Hohenforst-Schmidt W, Yarmus L, Huang H, Li Q, Freitag L, Zarogoulidis K.

Int J Pharm. 2013 Nov 18;456(2):325-31. doi: 10.1016/j.ijpharm.2013.09.004. Epub 2013 Sep 11.

PMID:
24035789
4.

New insights in the production of aerosol antibiotics. Evaluation of the optimal aerosol production system for ampicillin-sulbactam, meropenem, ceftazidime, cefepime and piperacillin-tazobactam.

Zarogoulidis P, Kioumis I, Ritzoulis C, Petridis D, Darwiche K, Porpodis K, Spyratos D, Parrish S, Browning R, Li Q, Turner JF, Freitag L, Zarogoulidis K.

Int J Pharm. 2013 Oct 15;455(1-2):182-8. doi: 10.1016/j.ijpharm.2013.07.040. Epub 2013 Jul 23.

PMID:
23891745
5.

Establishing the optimal nebulization system for paclitaxel, docetaxel, cisplatin, carboplatin and gemcitabine: back to drawing the residual cup.

Zarogoulidis P, Petridis D, Ritzoulis C, Darwiche K, Spyratos D, Huang H, Goldberg EP, Yarmus L, Li Q, Freitag L, Zarogoulidis K.

Int J Pharm. 2013 Sep 10;453(2):480-7. doi: 10.1016/j.ijpharm.2013.06.011. Epub 2013 Jun 14.

PMID:
23769993
6.

In vitro characteristics of tobramycin aerosol from ultrasonic and jet nebulizers.

Asmus MJ, Milavetz G, Tice AL, Teresi ME.

Pharmacotherapy. 2001 May;21(5):534-9.

PMID:
11349742
7.

Design principles of liquid nebulization devices currently in use.

Rau JL.

Respir Care. 2002 Nov;47(11):1257-75; discussion 1275-8. Review.

PMID:
12425742
8.

Formulations generated from ethanol-based proliposomes for delivery via medical nebulizers.

Elhissi AM, Karnam KK, Danesh-Azari MR, Gill HS, Taylor KM.

J Pharm Pharmacol. 2006 Jul;58(7):887-94.

PMID:
16805947
9.

Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol.

Zarogoulidis P, Kioumis I, Lampaki S, Organtzis J, Porpodis K, Spyratos D, Pitsiou G, Petridis D, Pataka A, Huang H, Li Q, Yarmus L, Hohenforst-Schmidt W, Pezirkianidis N, Zarogoulidis K.

Drug Des Devel Ther. 2014 Aug 12;8:1065-72. doi: 10.2147/DDDT.S66576. eCollection 2014.

10.

Albuterol delivery in an in vitro pediatric ventilator lung model: comparison of jet, ultrasonic, and mesh nebulizers.

Sidler-Moix AL, Dolci U, Berger-Gryllaki M, Pannatier A, Cotting J, Di Paolo ER.

Pediatr Crit Care Med. 2013 Feb;14(2):e98-102. doi: 10.1097/PCC.0b013e3182712783.

PMID:
23287904
11.
12.

Effect of nebulizer type and antibiotic concentration on device performance.

Weber A, Morlin G, Cohen M, Williams-Warren J, Ramsey B, Smith A.

Pediatr Pulmonol. 1997 Apr;23(4):249-60.

PMID:
9141110
13.

Inhalation of tobramycin in cystic fibrosis. Part 1: the choice of a nebulizer.

Le Brun PP, de Boer AH, Gjaltema D, Hagedoorn P, Heijerman HG, Frijlink HW.

Int J Pharm. 1999 Nov 5;189(2):205-14.

PMID:
10536249
14.
15.

Influence of realistic airflow rate on aerosol generation by nebulizers.

Vecellio L, Kippax P, Rouquette S, Diot P.

Int J Pharm. 2009 Apr 17;371(1-2):99-105. doi: 10.1016/j.ijpharm.2008.12.027. Epub 2008 Dec 27.

PMID:
19150494
16.

Nebulization of fluids of different physicochemical properties with air-jet and ultrasonic nebulizers.

McCallion ON, Taylor KM, Thomas M, Taylor AJ.

Pharm Res. 1995 Nov;12(11):1682-8.

PMID:
8592670
17.

Aerosol production and aerosol droplet size distribution during mechanical ventilation (IPPV) with a new ultrasonic nebulizer.

Kemming GI, Kreyling W, Habler O, Merkel M, Kleen M, Welte M, Messmer K, Zwissler B.

Eur J Med Res. 1996 Apr 18;1(7):321-7.

PMID:
9364032
18.

Design characteristics for drug nebulizers.

Dennis JH, Hendrick DJ.

J Med Eng Technol. 1992 Mar-Apr;16(2):63-8.

PMID:
1404307
19.

Physical properties of aerosols produced by several jet- and ultrasonic nebulizers.

Sterk PJ, Plomp A, van de Vate JF, Quanjer PH.

Bull Eur Physiopathol Respir. 1984 Jan-Feb;20(1):65-72.

PMID:
6704568
20.

Factors affecting aerosol performance during nebulization with jet and ultrasonic nebulizers.

Steckel H, Eskandar F.

Eur J Pharm Sci. 2003 Aug;19(5):443-55.

PMID:
12907295

Supplemental Content

Support Center